Header Logo

Connection

Cheryl Cohen to Respiratory Syncytial Virus, Human

Back to Details
This is a "connection" page, showing publications Cheryl Cohen has written about Respiratory Syncytial Virus, Human.
Cheryl Cohen
Connection Strength
8,670
Respiratory Syncytial Virus, Human
  1. Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 - 2018. BMC Infect Dis. 2024 Oct 09; 24(1):1128.
    View in: PubMed
    Score: 0,814
  2. Incidence and transmission of respiratory syncytial virus in urban and rural South Africa, 2017-2018. Nat Commun. 2024 01 02; 15(1):116.
    View in: PubMed
    Score: 0,772
  3. The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016. Int J Infect Dis. 2023 Sep; 134:71-77.
    View in: PubMed
    Score: 0,739
  4. The national burden of influenza-like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013-2015. Influenza Other Respir Viruses. 2022 05; 16(3):438-451.
    View in: PubMed
    Score: 0,677
  5. Deaths from RSV in young infants-the hidden community burden. Lancet Glob Health. 2022 02; 10(2):e169-e170.
    View in: PubMed
    Score: 0,676
  6. Cohort profile: A Prospective Household cohort study of Influenza, Respiratory syncytial virus and other respiratory pathogens community burden and Transmission dynamics in South Africa, 2016-2018. Influenza Other Respir Viruses. 2021 11; 15(6):789-803.
    View in: PubMed
    Score: 0,651
  7. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 07; 26(29).
    View in: PubMed
    Score: 0,649
  8. The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus-associated Severe Respiratory Illness in South African Infants, 2011-2016. Clin Infect Dis. 2019 11 27; 69(12):2208-2211.
    View in: PubMed
    Score: 0,581
  9. Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014. J Pediatric Infect Dis Soc. 2019 Sep 25; 8(4):325-333.
    View in: PubMed
    Score: 0,574
  10. The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access. Lancet Infect Dis. 2024 Dec; 24(12):e747-e761.
    View in: PubMed
    Score: 0,203
  11. Early life respiratory syncytial virus disease-a preventable burden. Lancet Infect Dis. 2024 Aug; 24(8):794-795.
    View in: PubMed
    Score: 0,197
  12. Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis. J Infect Dis. 2024 Mar 01; 229(Supplement_1):S25-S33.
    View in: PubMed
    Score: 0,195
  13. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa. Influenza Other Respir Viruses. 2023 Dec; 17(12):e13229.
    View in: PubMed
    Score: 0,192
  14. TNFAIP3-interacting protein 1 polymorphisms and their association with symptomatic human respiratory syncytial virus infection and bronchiolitis in infants younger than one year from South Africa: A case-control study. Int J Infect Dis. 2023 Nov; 136:107-110.
    View in: PubMed
    Score: 0,189
  15. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. BMC Med. 2023 03 31; 21(1):120.
    View in: PubMed
    Score: 0,183
  16. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis. 2023 01; 23(1):e2-e21.
    View in: PubMed
    Score: 0,175
  17. Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012-2015. Influenza Other Respir Viruses. 2022 03; 16(2):222-235.
    View in: PubMed
    Score: 0,165
  18. Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries. Influenza Other Respir Viruses. 2021 11; 15(6):732-741.
    View in: PubMed
    Score: 0,163
  19. Temporal Variations in Respiratory Syncytial Virus Epidemics, by Virus Subtype, 4 Countries. Emerg Infect Dis. 2021 05; 27(5):1537-1540.
    View in: PubMed
    Score: 0,160
  20. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. 2019 08; 7(8):e1031-e1045.
    View in: PubMed
    Score: 0,142
  21. Deaths associated with respiratory syncytial and influenza viruses among persons =5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis. 2015 Apr; 21(4):600-8.
    View in: PubMed
    Score: 0,105
  22. Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S217-26.
    View in: PubMed
    Score: 0,096
  23. Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S227-37.
    View in: PubMed
    Score: 0,096
  24. Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S246-54.
    View in: PubMed
    Score: 0,096
  25. The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya. BMC Public Health. 2024 09 04; 24(1):2410.
    View in: PubMed
    Score: 0,051
  26. Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study. J Infect. 2024 May; 88(5):106154.
    View in: PubMed
    Score: 0,049
  27. Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis. Lancet Infect Dis. 2024 Apr; 24(4):361-374.
    View in: PubMed
    Score: 0,048
  28. Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017 10; 75(4):346-355.
    View in: PubMed
    Score: 0,031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.